Verapamil inhibits ferroptosis in septic acute lung injury by blocking L-type calcium channels

Biochem Biophys Res Commun. 2025 Jan:744:151202. doi: 10.1016/j.bbrc.2024.151202. Epub 2024 Dec 18.

Abstract

Acute lung injury (ALI) and its severe form, acute respiratory distress syndrome (ARDS), result from pulmonary edema and alveolar-capillary barrier disruption due to inflammation, often triggered by conditions like sepsis. Sepsis-induced ALI (SALI) involves extensive damage to vascular endothelium and alveolar epithelium, leading to respiratory failure. Our study explores ferroptosis, an iron-dependent cell death pathway, and calcium dysregulation in SALI. Elevated cytosolic calcium early in ferroptosis exacerbates lipid peroxidation and cellular damage. We investigated verapamil, a calcium channel blocker, and found it reduces calcium influx, alleviates iron overload, and decreases oxidative stress, protecting against ferroptosis-induced apoptosis in lung cells. These insights suggest targeting ferroptosis pathways, including calcium and iron homeostasis, may offer new therapeutic strategies for SALI, potentially improving outcomes in ALI/ARDS.

Keywords: Calcium; Ferroptosis; LTCC; SALI; Verapamil.

MeSH terms

  • Acute Lung Injury* / drug therapy
  • Acute Lung Injury* / metabolism
  • Acute Lung Injury* / pathology
  • Animals
  • Calcium / metabolism
  • Calcium Channel Blockers* / pharmacology
  • Calcium Channel Blockers* / therapeutic use
  • Calcium Channels, L-Type* / metabolism
  • Ferroptosis* / drug effects
  • Humans
  • Iron / metabolism
  • Oxidative Stress / drug effects
  • Sepsis* / complications
  • Sepsis* / drug therapy
  • Sepsis* / metabolism
  • Sepsis* / pathology
  • Verapamil* / pharmacology

Substances

  • Verapamil
  • Calcium Channels, L-Type
  • Calcium Channel Blockers
  • Calcium
  • Iron